Bayer Aktiengesellschaft (ETR: BAYN)
Germany
· Delayed Price · Currency is EUR | Market Cap | 25.92B |
| Revenue (ttm) | 47.01B |
| Net Income (ttm) | -3.12B |
| Shares Out | 982.42M |
| EPS (ttm) | -3.17 |
| PE Ratio | n/a |
| Forward PE | 5.17 |
| Dividend | 0.11 (0.42%) |
| Ex-Dividend Date | Apr 29, 2024 |
| Volume | 2,907,526 |
| Open | 26.18 |
| Previous Close | 26.11 |
| Day's Range | 26.14 - 26.64 |
| 52-Week Range | 24.96 - 53.80 |
| Beta | 0.95 |
| Analysts | n/a |
| Price Target | 33.80 (+28.13%) |
| Earnings Date | Aug 6, 2024 |
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter med... [Read more]
Financial Performance
Financial StatementsNews
Bayer and Rad AI Announce Collaboration agreement
NATIONAL HARBOR, Md.--(BUSINESS WIRE)--As experts from around the globe gather at the annual Society for Informatics in Medicine (SIIM) conference, Bayer and Rad AI are announcing a collaboration to b...
Bayer's pharmaceutical unit plans more managerial cuts in Europe, Asia
A top Bayer pharmaceutical executive said on Wednesday his group will continue slashing managerial jobs this year, planning cuts in Germany, Japan, the United Kingdom, Belgium and the Netherlands as p...
Bayer and Solynta Collaborate to Advance True Potato Seed in Smallholder Markets
WAGENINGEN, Netherlands--(BUSINESS WIRE)--Bayer and Solynta have reached an agreement to collaborate on the commercialization and distribution of true potato seeds in Kenyan and Indian markets. This p...
Bayer lobbies Congress to help fight lawsuits tying Roundup to cancer
Republicans have repeatedly pushed a provision — drafted with Bayer’s help — that critics say would undo some nationwide pesticide protections.
Bayer looks to AI to combat herbicide resistance faster
Bayer's crop science division is increasingly turning to artificial intelligence in its battle against crop killing weeds, the company told Reuters.
Enveda raises $55M to combine ancient remedies with AI for drug discovery
For centuries, people chewed willow tree bark to relieve pain, but scientists at chemical firm Bayer didn’t isolate its active ingredient until the 1800s and eventually patented its modified version a...
Bayer Collaborates with PAPACKS to Co-create Alternative-to-Plastic Packaging for Consumer Health Products (FOTO)
Basel, Switzerland (ots) - This relationship aims to advance Bayer's commitment to ensure 100% of product packaging is recycle-ready or reusable by 2030 Bayer has launched a strategic collaboration wi...
Brent Wisner, the LA lawyer taking on GSK
Attorney who made name winning billions of dollars against Bayer has received a big boost in Zantac cancer case
Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M
A Pennsylvania judge on Tuesday drastically reduced a $2.25 billion verdict against Bayer AG (OTC: BAYRY), cutting it down to $400 million in a case involving a man who claimed he developed cancer fr...
Wall Street Breakfast Podcast: PA Court Cuts Bayer's Roundup Verdict From $2.25B To $400M
Bayer's $2.25B Roundup verdict cut to $400M by Pennsylvania judge
A Philadelphia court reduces Bayer's payout from $2.25B to $400M in a case involving Roundup weedkiller and cancer.
Judge cuts Bayer $2.25 billion Roundup verdict to $400 million
A Pennsylvania judge on Tuesday slashed a $2.25 billion U.S. verdict against Bayer to $400 million for a Pennsylvania man who said he developed cancer from exposure to the company's Roundup weedkiller...
Burning Rock Biotech joins hands with Bayer to expand precision cancer therapies portfolio
Burning Rock Biotech (BNR) and Bayer (BAYRY) are collaborating to develop NGS-based CDx companion diagnostic products for Bayer's expanding precision cancer therapies portfolio in China.
Hannah Oh and Marcelo Duarte to Join Verde's Board of Directors, Subject to Shareholders' Approval
SINGAPORE, May 28, 2024 (GLOBE NEWSWIRE) -- Verde AgriTech Ltd (TSX: "NPK") (" Verde " or the " Company ") is pleased to announce that Hannah Oh and Marcelo Duarte (the " Directors ") have been recomm...
Bayer Sees 'Existential' Threat From Roundup Suits, CEO Says
Bayer AG Chief Executive Officer Bill Anderson said the wave of lawsuits over its widely used weedkiller Roundup is an "existential" threat to the company and farmers.
How Bayer monitors complex ocean shipments to avoid supply-chain disruptions
Bayer implemented FourKites' AI-powered real-time tracking in 2021 to keep tabs on time-sensitive domestic and global shipments.
Bayer is going all in to create legal shields in Missouri, Iowa and Idaho against 170,000 weedkiller lawsuits it faces
The lawsuits allege Roundup's key ingredient, glyphosate, causes a cancer called non-Hodgkin lymphoma.
Bayer, maker of Roundup weedkiller, steps up fight against cancer-related lawsuits
JEFFERSON CITY, Mo. — After failing in several U.S. states this year, global chemical manufacturer Bayer said Tuesday that it plans to amplify efforts to create a legal shield against a proliferation ...
Pharma giant Bayer's shares have fallen 70% in 6 years—but its football team, the best in Germany, is thriving
Bayer is still a major sponsor of its football team, although it’s unclear how much it pumps in each season. It’s unlikely the investment will decrease any time soon under CEO Anderson.
A German Soccer Club Just Can’t Stop Winning. Its Owner Is Struggling Pharma Giant Bayer
Xabi Alonso’s team’s dominance has offered a morale boost for the struggling pharma giant, where employees have been accustomed to an overflow of bad news.
Bayer hot flashes treatment elinzanetant meets goals in late-stage trials
Bayer's phase 3 studies show elinzanetant effectively reduced frequency and severity of hot flashes associated with menopause. Read more here.
Elinzanetant significantly reduces frequency and severity of moderate to severe hot flashes associated with menopause
Late-breaking data from pivotal Phase III studies OASIS 1 and 2 to be presented at 2024 ACOG Annual Meeting: Pivotal OASIS 1 and 2 Phase III studies of investigational compound elinzanetant achieved a...
Bayer presents latest data from oncology portfolio at 2024 ASCO Annual Meeting
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer will present new data across its oncology portfolio at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting, taking place in Chicago, from Ma...
Bayer: Small Signs Of Improvement Are Not Enough
Bayer's solid Q1 results with modest sales decline, impacted by currency headwinds. Read why BAYRY stock is certainly a risky investment.
Bayer Starts Phase I Study With Novel Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer
BERLIN--(BUSINESS WIRE)--Bayer announced today initiation of dosing in a Phase I first-in-human clinical study with 225Ac-PSMA-Trillium (BAY 3563254), a next-generation targeted alpha therapy. The inv...